A groundbreaking study published in Cardiovascular Research unveils AB-Biotics’ AB-Life probiotic strains’ profound cardiometabolic benefits in combating atherosclerotic cardiovascular diseases (ACVDs). Led by AB-Biotics, the research demonstrates how AB-Life, containing Lactiplantibacillus plantarum strains, reduces LDL particle sizes and apolipoproteins, pivotal biomarkers in atherosclerosis development. The study highlights the probiotics’ role in bile acid metabolism, lowering LDL-C and ApoB protein levels, while also improving gut microbiota composition and offering protection against dyslipidemia. This discovery underscores the potential of probiotics in enhancing cardiovascular health and prompts further investigation into their therapeutic applications.
Home » AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
AB-Biotics’ AB-Life Probiotic: A Heart-Healthy Breakthrough Unveiled!
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
A Little Fat Goes a Long Way for Malaria Treatment
October 21, 2026
Grapefruit juice increases the bioavailability of artemether
October 21, 2026
PQQ for Mitochondrial Rejuvenation and Skin Aging
October 13, 2026
Ciona robusta as a Marine Cosmetic Ingredient for Skin Hydration
October 13, 2026